Team:Slovenia/Project/Motivation

<html>
<head>
	<link rel="stylesheet" type="text/css" href="http://www.obrazuspeha.si/css_igem_slo08/default.css">

<!-- dd menu -->
<script type="text/javascript">
<!--
var timeout         = 500;
var closetimer		= 0;
var ddmenuitem      = 0;

// open hidden layer
function mopen(id)
{	
	// cancel close timer
	mcancelclosetime();

	// close old layer
	if(ddmenuitem) ddmenuitem.style.visibility = 'hidden';

	// get new layer and show it
	ddmenuitem = document.getElementById(id);
	ddmenuitem.style.visibility = 'visible';

}
// close showed layer
function mclose()
{
	if(ddmenuitem) ddmenuitem.style.visibility = 'hidden';
}

// go close timer
function mclosetime()
{
	closetimer = window.setTimeout(mclose, timeout);
}

// cancel close timer
function mcancelclosetime()
{
	if(closetimer)
	{
		window.clearTimeout(closetimer);
		closetimer = null;
	}
}

// close layer when click-out
document.onclick = mclose; 
// -->
</script>

</head>

</html>
<!------------------------------- ZACETEK IGEM 2008 STRANI ------------------------------------------------------>
<html>
<table border="0" cellspacing="0" cellpadding="0" width="80%" align="center" >
<tr>
<td>
<!-- Zacetek slike logo -->
</html>
[[Image:Igem-logo-900x200-1-2.jpg|900px|center]]
<html>
<!-- konec slike logo -->
</td>
</tr>
<tr>
<td>
<!-- zacetek meni-ja -->
<center>
<div align="center" style="width:900px; background-color:#528e68; text-align:center;"><!--<img src="https://static.igem.org/mediawiki/2008/0/05/IGEM-Slovenia_btn_v2_1.gif" align="center" width="900" height="30" border="0" usemap="#Map" />-->
<ul id="sddm">
<li><a href="https://2008.igem.org/Team:Slovenia" target="_self" ><img src="https://static.igem.org/mediawiki/2008/b/b7/Home_btn.gif" width="64" height="30" border="0" /></a></li>

<li><a href="https://2008.igem.org/Team:Slovenia/Background" target="_self" onmouseover="mopen('m1')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/c/ca/Background_btn.gif" width="138" height="30" border="0" /></a>
		<div id="m1" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
		<a href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</a>
		<a href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</a>
<a href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</a>
		</div>
	</li>

<li><a href="https://2008.igem.org/Team:Slovenia/Project" target="_self" onmouseover="mopen('m2')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/2/23/Project_btn.gif" width="138" height="30" border="0" /></a>
		<div id="m2" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
		<a href="#" target="_self">Motivation</a>
		<a href="https://2008.igem.org/Team:Slovenia/Project/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</a>
		<a href="https://2008.igem.org/Team:Slovenia/Project/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
		</div>
	</li>

<li><a href="https://2008.igem.org/Team:Slovenia/Results" target="_self" onmouseover="mopen('m3')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/4/49/Results_btn.gif" width="96" height="30" border="0" /></a>
		<div id="m3" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
		<a href="https://2008.igem.org/Team:Slovenia/Results/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</a>
		<a href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</a>
		<a href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">"Real-life" results</a>
<a href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</a>
		</div>
	</li>
<!-- tukaj je slika menija conclusion -->
<li><a href="https://2008.igem.org/Team:Slovenia/Conclusions" target="_self" ><img src="https://static.igem.org/mediawiki/2008/b/bd/Biobricks_btn.gif" width="138" height="30" border="0" /></a></li>
<!-- konec slike menija conclusion -->

<li><a href="https://2008.igem.org/Team:Slovenia/Notebook" target="_self" onmouseover="mopen('m4')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/8/8e/Notebook_btn.gif" width="114" height="30" border="0" /></a>
		<div id="m4" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
		<a href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</a>
		<a href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</a>
		<a href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</a>
                <a href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</a>
		</div>
	</li>


<li><a href="https://2008.igem.org/Team:Slovenia/Team" target="_self" ><img src="https://static.igem.org/mediawiki/2008/7/73/Team_btn.gif" width="109" height="30" border="0" /></a></li>
	
	
<li><a href="https://2008.igem.org/Team:Slovenia/Credits" target="_self" onmouseover="mopen('m5')" onmouseout="mclosetime()"><img src="https://static.igem.org/mediawiki/2008/d/d4/Sponsors_btn.gif" width="103" height="30" border="0" /></a>
<div id="m5" onmouseover="mcancelclosetime()" onmouseout="mclosetime()">
		<a href="https://2008.igem.org/Team:Slovenia/Acknowledgements" target="_self">Acknowledgements</a>
		<a href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self">Sponsors</a>
		</div>
	</li>
</ul>
<div style="clear:both"></div>

<div style="clear:both"></div>
</div>
</center>
<!-- konec menija -->
<td>
</tr>
<tr>
<td align="center">
<p style="font-family:Verdana; font-size:12px;"><br /><br />
</html>
<!-- #################################################
######################################################

PROSTOR ZA NASLOV JE PRIPRAVLJEN ZA ZNAKOM (minus minus je večje). V 5.vrstici od trenutne!

#################################################
######################################################
-->

<html>
</p>
</td>
</tr>
<tr>
<td align="justify">
<p> 
</html>
<!-- #################################################
######################################################

PROSTOR ZA TEKST JE PRIPRAVLJEN ZA ZNAKOM (minus minus je večje). V 6.vrstici od trenutne!

#################################################
######################################################
-->
<html><center>
<font size="5" color="#000000"><i><b>Motivation</b></i></font> 
</center></html>


----
<p>&nbsp;</p>
<p class="MsoNormal" style="line-height: 150%;"><strong><span lang="EN-US" style="font-size: 14pt; line-height: 150%;">The Goal &ndash; designer vaccine against <i>Helicobacter pylori</i></span></strong> <span style="font-family: Comic Sans MS;"><strong><span lang="EN-US" style="font-size: 13pt; line-height: 150%;">&agrave; la Synthetic biology</span></strong></span></p>
<p>&nbsp;</p>

<p class="MsoBodyText"><span lang="EN-US">Response and sensing of the <b>immune system is modular</b> and activators of immune response are composed of discrete elements such as peptides, binding to the cellular receptors, bacterial or viral compounds that activate different cellular receptors that drive the polarization of immune response. Those stimulators that occur in different combinations in pathogenic microorganisms can be artificially combined into defined functional vaccines.</span></p>
<p class="MsoBodyText"><b><span lang="EN-US">Modular</span></b> <span lang="EN-US"><b>approach of Synthetic biology</b> can therefore offer powerful tools either based on bacteria as cell factories to produce advanced protein vaccines or to modify host cells by DNA vaccine in order to mount efficient immune protection.</span></p>



<p class="MsoNormal" style="text-align: justify;"><span lang="EN-US">An effective vaccine has to combine activation of the receptors of innate immunity and appropriate processing and presentation of antigens of a pathogen (see Background). Our idea was to combine antigens and activators of innate immune receptors into a single engineered molecule or gene construct. Bacteria <i>H. pylori</i> was selected as a target, to paraphrase JFK, &ldquo;<i>not because it is easy but because it is hard</i>&rdquo;. Its survival under harsh conditions and particularly avoidance of immune recognition (see Background) made it a formidable challenge and opportunity to try to outsmart it with tricks of synthetic immunology.</span></p>
<p>&nbsp;</p>

<p class="MsoNormal" style="text-align: justify;"><b><span lang="EN-US" style="font-size: 14pt;">The Project idea</span></b></p>
<p>&nbsp;</p>

<p class="MsoNormal" style="text-align: justify;"><span lang="EN-US">In order to achieve stimulation of innate immunity by proteins of <i>H. pylori</i>, which otherwise avoids immune recognition, we designed two tracks to prepare a high-tech vaccine:</span></p>

<table cellspacing="1" cellpadding="1" align="left" class="pbNotSortable" style="width: 589px; height: 119px;">
    
        <tr>
            <td bgcolor="#ffffcc" style="border-color: rgb(0, 0, 0); background-color: rgb(255, 255, 204);">
            <p class="MsoNormal" style="text-align: justify;"><b><span lang="EN-US">Track 1</span></b><span lang="EN-US">: <b>Engineered <i>H. pylori</i> flagellin</b></span><strong><span lang="EN-US">-based vaccine</span></strong></p>
            <p class="MsoNormal" style="text-align: justify;"><span lang="EN-US">This type of engineered vaccine will be composed of different modules, each activating a selected arm of the immune response.</span> <span lang="EN-US">Flagellin of <i>H. pylori</i>, which avoids activation&nbsp;of innate response receptor TLR5, will be engineered to regain activation of TLR5 and &quot;become visible to the immune system&quot;, while it will retain the central most antigenic segment as a target of adaptive immune response. Additional immunobricks containing protein antigens and comprising several rationally selected epitopes will be added to increase the spectrum of proteins recognized by produced antibodies.<br />
            </span></p>
            </td>
        </tr>
    
</table>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><span lang="EN-US">&nbsp;</span></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><span lang="EN-US">&nbsp;</span></p>

<table cellspacing="1" cellpadding="1" align="left" class="pbNotSortable" style="width: 589px; height: 199px;">

<p class="MsoNormal" style="text-align: justify;">&nbsp;</p>

        <tr>
            <td bgcolor="#ffffcc" style="border-color: rgb(0, 0, 0); background-color: rgb(255, 255, 204);">
            <p class="MsoNormal" style="text-align: justify;"><b><span lang="EN-US">Track 2</span></b><span lang="EN-US">: <b>Antigen-TLR fusion vaccine</b> was designed to bypass the requirement of TLR agonists<span>&nbsp;</span>and provide the ability to trigger different signaling pathways or their combinations that result in antigen processing and presentation and production of a distinct set of costimulatory molecules. The main objective within this track was to</span> <span lang="EN-US">prepare constructs with <b>constitutively active Toll-like receptors</b> that are:</span></p>
            <p class="MsoNormal" style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><span lang="EN-US" style="font-family: Symbol;"><span>&middot;<span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span> <b><span lang="EN-US">fused to antigens</span></b><span lang="EN-US">,</span></p>
            <p class="MsoNormal" style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><span lang="EN-US" style="font-family: Symbol;"><span>&middot;<span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span> <span lang="EN-US"><b>localized</b></span> <span lang="EN-US"><b>within the activated endosomes</b>,</span></p>
            <p class="MsoNormal" style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><span lang="EN-US" style="font-family: Symbol;"><span>&middot;<span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span> <span lang="EN-US">where antigen is processed into <b>peptides that are loaded to MHC II</b> or</span></p>
            <p class="MsoNormal" style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><span lang="EN-US" style="font-family: Symbol;"><span>&middot;<span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span> <b><span lang="EN-US">presented at cell surface</span></b> <span lang="EN-US">to engage B-cell receptors while</span></p>
            <p class="MsoNormal" style="margin-left: 18pt; text-indent: -18pt; text-align: justify;"><span lang="EN-US" style="font-family: Symbol;"><span>&middot;<span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; font-weight: normal; font-size: 7pt; line-height: normal; font-size-adjust: none; font-stretch: normal;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></span> <span lang="EN-US">TLR activation additionally <b>provides costimulatory signals</b> to neighboring cells.</span></p>
            </td>
        </tr>
    
</table>
<p class="MsoNormal" style="text-align: justify;">&nbsp;&nbsp;</p>
<p><span style="font-size: 100%;"><span style="font-family: Arial;">&nbsp;</span></span></p>

<html> 
</p>
</td>
</tr>
<tr>
<td align="center">
<br /><br /><br /><br />

</td>
</tr>
</table>
</html>
<!------------------------------- KONEC IGEM 2008 STRANI ------------------------------------------------------>